Instructor in Pediatrics, Cambridge Health Alliance
Psychiatry
Dr. Gustavo D. Kinrys, MD
|
|
Give Review
Gustavo D. Kinrys, MD practices Psychiatry. He went to medical school at Baylor College of Medicine. Gustavo D. Kinrys is a published MD as well. He has 37 publications published. The latest was: Baseline disability and poor functioning in bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- A tool to predict suicidal ideation and behavior in Bipolar disorder: The Concise Health Risk Tracking Self-Report.
- Medical burden in Bipolar disorder: findings from the Clinical and Health Outcomes Initiative in Comparative Effectiveness for Bipolar Disorder study (Bipolar CHOICE).
- Psychotherapy use in Bipolar disorder: Association with functioning and illness severity.
- Complexity of Illness and Adjunctive Benzodiazepine Use in Outpatients With Bipolar I or II Disorder: Results From the Bipolar CHOICE Study.
- A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of the Augmentation of a Nicotinic Acetylcholine Receptor Partial Agonist in Depression: Is There a Relati...
- Corrigendum to "Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with Bipolar I or II disorder: Results from the...
- Effect of adjunctive benzodiazepines on clinical outcomes in lithium- or quetiapine-treated outpatients with Bipolar I or II disorder: results from the Bipolar CHOICE ...
- Clinical applications of herbal medicines for Anxiety and insomnia; targeting patients with bipolar disorder.
- Association of exercise with quality of life and mood symptoms in a comparative effectiveness study of Bipolar disorder.
- Lithium tremor revisited: pathophysiology and treatment.
- Assessment of a multi-assay, serum-based biological diagnostic test for major depressive Disorder: a Pilot and Replication Study.
- Retention in mental health care of Portuguese-speaking patients.
- A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive Disorder.
- The use of referenced-EEG (rEEG) in assisting medication selection for the treatment of depression.
- Pharmacologic alternatives to antidepressants in posttraumatic stress Disorder: a systematic review.
- Natural remedies for Anxiety disorders: potential use and clinical applications.
- Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized Anxiety disorder.
- [Antipsychotics, anticonvulsants, antiadrenergics and other drugs: what to do when posttraumatic stress Disorder does not respond to selective serotonin reuptake inhib...
- Levetiracetam as adjunctive therapy for refractory Anxiety disorders.
- Adjunctive zonisamide for treatment refractory Anxiety.
- An open-label trial of risperidone augmentation for refractory Anxiety disorders.
- Levetiracetam for treatment-refractory posttraumatic stress Disorder.
- The combination of duloxetine and bupropion for treatment-resistant major depressive Disorder.
- [Anxiety disorders in women: does gender matter to treatment?].
- Aripiprazole augmentation of selective serotonin reuptake inhibitors for treatment-resistant major depressive Disorder.
- Olanzapine augmentation of fluoxetine for refractory generalized Anxiety disorder: a placebo controlled study.
- Anticonvulsants in Anxiety disorders.
- Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and Anxiety disorder patients.
- An open-label study of levetiracetam for the treatment of social Anxiety disorder.
- Bupropion sustained release for panic Disorder.
- Citalopram for social Anxiety disorder: an open-label pilot study in refractory and nonrefractory patients.
- Valproic acid for the treatment of social Anxiety disorder.
- Steroid-responsive confusion associated with thyroiditis.
- Hypomania associated with omega3 fatty acids.
- Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): a pragmatic 6-month trial of lithium versus quetiapine for Bipolar disorder.
- Baseline disability and poor functioning in Bipolar disorder predict worse outcomes: results from the Bipolar CHOICE study.
Conditions Treated
- Alcoholism (Alcohol Dependence)
- Anxiety
- Bipolar Disorder
- Drug and Alcohol Dependence
- View All
Doctors Specialties
- Psychiatry
Accepted Insurances
Education
-
Mayo School of Graduate Medical Education -
Mount Sinai Beth Israel -
Baylor College of Medicine -
Faculdade de Medicina da Universidade Federal do Rio de Janeiro
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1023076676 | |
| NPPES Provider LastName | KINRYS | |
| NPPES Provider FirstName | GUSTAVO | |
| NPPES Provider ZIPCode | 021411131 | |
| NPPES Provider State | MA | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 239.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1023076676 |
| Last Name Of The Provider | KINRYS |
| First Name Of The Provider | GUSTAVO |
| View All |
Similar Doctors
|
|
Dr. Michael E. Dvorkin, ED.D
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Justin A. Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anton Pesok, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chaya G. Bhuvaneswaran, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Evgeniy E. Filin, MD
This Doctor is OpenDoctor Recommended.
|